In the light of these results, CLA appears to be a potent anticancer agent, as it not only elevates the expression of PPAR-γ, but it also acts as its ligand, contributing to decreased NSCLC cells proliferation. This evidence concerns the gene PPARG and non-small cell lung carcinoma.